This study investigates the management of pancreatic tumors using endoscopic ultrasound-guided radiofrequency ablation.
The study evaluates how safe and effective this method is for treating pancreatic tumors. It looks at both short-term and long-term outcomes of the treatment.
- Who can participate: Adults over 18 with pancreatic cystic lesions at least 2 cm in size, who are not candidates for surgery, may participate. Participants must be able to give consent and have a life expectancy of at least one year.
- Study details: Participants will undergo a procedure called radiofrequency ablation using endoscopic ultrasound guidance. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.
- Study timelines: The study will last up to 3 years.